NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units to ...

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? The Centers for Disease Control and Prevention abruptly ordered its staff to ...

Novavax (NASDAQ:NVAX) stock is on the rise Friday after the biotechnology company announced a deal with Sanofi (NASDAQ:SNY) alongside its first-quarter earnings report. The big news here is the ...

Shortly after President-elect Donald J ... Cynically, though, the SARS-CoV-2 virus brought NVAX stock back into the game. Of course, the recovery story was relatively short-lived.

Shares of Novavax Inc. NVAX slid 3.09% to $7.83 Wednesday, on what proved to be an all-around mixed trading session for the ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Novavax (NVAX ...

Novavax Inc. closed 66.14% below its 52-week high of $23.86, which the company reached on June 6th.

So, it is worth exploring what lies ahead for the stock. The average of price targets set by Wall Street analysts indicates a potential upside of 81.6% in Novavax (NVAX). While the effectiveness of ...

While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Novavax (NVAX) has received ...